NARI Inari Medical Inc

Price (delayed)

$71.08

Market cap

$3.78B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.02

Enterprise value

$3.62B

Inari Medical, Inc. is a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases. Inari has developed two minimally-invasive, ...

Highlights
The quick ratio has soared by 110% from the previous quarter and by 8% YoY
The equity has soared by 96% year-on-year and by 75% since the previous quarter
The EPS has dropped by 110% since the previous quarter and by 107% year-on-year
NARI's net income has dropped by 108% since the previous quarter and by 104% year-on-year

Key stats

What are the main financial stats of NARI
Market
Shares outstanding
53.13M
Market cap
$3.78B
Enterprise value
$3.62B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
8.59
Price to sales (P/S)
11.82
EV/EBIT
19,665.93
EV/EBITDA
673.47
EV/Sales
11.81
Earnings
Revenue
$306.34M
EBIT
$184,000
EBITDA
$5.37M
Free cash flow
-$7.51M
Per share
EPS
-$0.02
Free cash flow per share
-$0.15
Book value per share
$8.27
Revenue per share
$6.01
TBVPS
$9.5
Balance sheet
Total assets
$484.11M
Total liabilities
$65.3M
Debt
$28.93M
Equity
$418.81M
Working capital
$377.76M
Liquidity
Debt to equity
0.07
Current ratio
11.62
Quick ratio
10.78
Net debt/EBITDA
-29.34
Margins
EBITDA margin
1.8%
Gross margin
90.2%
Net margin
-0.2%
Operating margin
0%
Efficiency
Return on assets
-0.2%
Return on equity
-0.3%
Return on invested capital
0.1%
Return on capital employed
0%
Return on sales
0.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

NARI stock price

How has the Inari Medical stock price performed over time
Intraday
2.66%
1 week
16.7%
1 month
16.85%
1 year
-25.8%
YTD
-22.12%
QTD
-21.58%

Financial performance

How have Inari Medical's revenue and profit performed over time
Revenue
$306.34M
Gross profit
$276.24M
Operating income
$49,000
Net income
-$758,000
Gross margin
90.2%
Net margin
-0.2%
NARI's net income has dropped by 108% since the previous quarter and by 104% year-on-year
Inari Medical's net margin has plunged by 106% from the previous quarter and by 102% YoY
The operating income has plunged by 100% YoY and by 100% from the previous quarter
The company's operating margin has shrunk by 100% QoQ and by 100% YoY

Growth

What is Inari Medical's growth rate over time

Valuation

What is Inari Medical stock price valuation
P/E
N/A
P/B
8.59
P/S
11.82
EV/EBIT
19,665.93
EV/EBITDA
673.47
EV/Sales
11.81
The EPS has dropped by 110% since the previous quarter and by 107% year-on-year
The equity has soared by 96% year-on-year and by 75% since the previous quarter
The price to book (P/B) is 51% lower than the last 4 quarters average of 17.1
The revenue has surged by 80% year-on-year and by 11% since the previous quarter
The P/S is 35% below the last 4 quarters average of 17.6

Efficiency

How efficient is Inari Medical business performance
The return on equity has dropped by 107% since the previous quarter and by 103% year-on-year
The company's return on assets has shrunk by 106% QoQ and by 103% YoY
NARI's return on invested capital has dropped by 100% year-on-year and by 99% since the previous quarter
The return on sales has dropped by 99% year-on-year and by 98% since the previous quarter

Dividends

What is NARI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NARI.

Financial health

How did Inari Medical financials performed over time
The quick ratio has soared by 110% from the previous quarter and by 8% YoY
The total assets has soared by 106% year-on-year and by 55% since the previous quarter
Inari Medical's debt is 93% less than its equity
The equity has soared by 96% year-on-year and by 75% since the previous quarter
NARI's debt to equity is down by 42% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.